More adult patients treated with WEGOVY compared with placebo had maximum changes from baseline at any visit of 10 to 19 bpm (41% versus 34%, respectively) and 20 bpm or more (26% versus 16%, respectively)
The decision depends on your individual symptom severity, baseline health, and how your body has responded to GLP-1 medications before infection
To diagnose this condition, medical professionals rule out other causes of symptoms, such as infections
Week 13 and beyond (if required): If the previous dose is well tolerated and further improvement in blood sugar control is needed, the dose may be increased to 2 mg once weekly
Studies suggest decreased central nervous system (CNS) cholesterol as the cause of the neurodevelopment manifestations of SLOS, as well as the high incidence of ASDs in this population (72)
This study, a collaboration between the Cancer Epidemiology Unit (CEU) in NDPH, and the International Agency for Research on Cancer (IARC) in Lyon, is the largest and most comprehensive investigation on IGF-1 and cancer risk to date
